NORTHFIELD, Ill., Aug. 12, 2014 /PRNewswire/ --New science in molecular and genetic testing forbreast, colon, and prostate cancer, as well as leukemia, will be among the special features at the College of American Pathologists' annual scientific and education meeting, CAP'14-THE Pathologists' Meeting, Sept. 7-10 at the Hyatt Regency in Chicago.
To view the multimedia assets associated with this release, please click: http://www.multivu.com/players/English/7270051-college-of-american-pathologists-cap-14-what-s-next-in-cancer-testing/
"More accurate diagnoses and precise treatments through molecular diagnostics offer new hope for the millions of patients battling cancer each year," said CAP President Gene N. Herbek, MD, FCAP. "As the doctors who diagnose disease and guide treatment, pathologists want to keep current on the new diagnostic procedures that can enhance patient care. CAP'14 brings together the leading experts in laboratory medicine to share the latest information to benefit patients."
World-renowned experts in pathology and laboratory medicine will examine the clinical and economic impact of genomic-based testing, as well as share insights on the pathologist's role in coordinated care models and appropriate test selection to reduce medical costs and unnecessary testing.
Highlighted scientific and educations courses to be covered include:
- Special Scientific Plenary Session: "Molecular Medicine-Can We Afford It?", lead by national thought leaders:
- Debra G.B. Leonard, MD, PhD, FCAP, chair of pathology at the University of Vermont
- David O. Meltzer, MD, PhD, a health economistat the University of Chicago
- Adam C. Berger, PhD, director of the Institute of Medicine's Roundtable on Translating Genomic-Based Research for Health
- Beyond the microscope, emerging technologies and new ways to guide clinical decision making
- The use clinical informatics in an era of meaningful use
View a complete list of CAP'14 media "hot topics" by day and by subject. Contact CAP Media for free media registration or to arrange an interview with an expert.
Highlighted events to be featured at CAP'14 include:
- "The Next 20 Years: How Science Will Revolutionize Medicine," featuring futurist and celebrated author, Michio Kaku, PhD
- The top five Junior member-submitted abstracts, representing original pathology research
- The "Path to a Future in Medicine" program honoring six of the best and brightest high school science students from the Chicago Public Schools.
About Pathologists
Sometimes called the "doctor's doctor," pathologists are physicians who use laboratory medicine to identify and diagnose disease from pre-birth to post-death. They work with other physicians on the patient care team to guide treatment for medical conditions, from diabetes to cancer.
About the College of American Pathologists
As the leading organization with more than 18,000 board-certified pathologists, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. The CAP's Laboratory Improvement Programs, initiated 65 years ago, currently has customers in more than 100 countries, accrediting 7,600 laboratories and providing proficiency testing to 20,000 laboratories worldwide. Find more information about the CAP at cap.org. Follow CAP on Twitter: @pathologists.
To view the multimedia assets associated with this release, please click: http://www.multivu.com/players/English/7270051-college-of-american-pathologists-cap-14-what-s-next-in-cancer-testing/
SOURCE College of American Pathologists
